Wang Lining entered into an agreement to acquire 0.77% stake in Changchun Changsheng Life Sciences Limited from Wang Shiduo, Xu Lei, and Chen Gu for CNY 19.9 million on October 15, 2014. Wang Shiduo will transfer 0.47% stake in Changchun Changsheng to Wang Lining for CNY 12.15 million; Xu Lei will transfer 0.24% stake in Changchun Changsheng to Wang Lining for CNY 6.25 million; Chen Gu will transfer 0.06% stake in Changchun Changsheng to Wang Lining for CNY 1.5 million. Changchun Changsheng Life Sciences Limited reported total assets of CNY 1.56 billion, total owner's equity of CNY 1 billion, revenue of CNY 622.62 million, operating profit of CNY 236.68 million and net profit of CNY 207.86 million as of December 31, 2014.
End-of-day quote
Other stock markets
|
||
- CNY | - |
1st Jan change | Capi. | |
---|---|---|
0.00% | 106M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- 002680 Stock
- News Changsheng Bio-technology Co Ltd
- Wang Lining entered into an agreement to acquire 0.77% stake in Changchun Changsheng Life Sciences Limited from Wang Shiduo, Xu Lei, and Chen Gu for CNY 19.9 million.